Skip to main content
. 2020 May;12(5):2963–2970. doi: 10.21037/jtd.2020.02.10

Table 3. In-hospital mortality and hospital length of stay analyzed by pre-transcatheter aortic valve replacement tricuspid regurgitation severity.

Variable Timing Tricuspid regurgitation severity P value
Trace/mild (0–1+) Moderate (2+) Severe (3–4+)
All-cause mortality Pre-TAVR 4/124 (3.2) 7/34 (20.6) 2/16 (12.5) 0.007
Post-TAVR 7/139 (5.0) 3/22 (13.6) 3/13 (23.1) 0.008
Cardiovascular mortality Pre-TAVR 2/124 (1.6) 5/34 (14.7) 1/16 (6.3) 0.027
Post-TAVR 4/140 (2.9) 1/22 (4.5) 3/13 (23.1) 0.003
Median length of hospital stay (days, IQR) Pre-TAVR 5 [3–10] 4 [6–20] 4 [3–9] 0.756
Post-TAVR 5 [3–9] 6 [4–11] 15 [4–20] 0.156

Variables presented as number (percentage), unless otherwise noted. TAVR, transcatheter aortic valve replacement.